These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33935100)

  • 1. Early Gross Motor Milestones in Duchenne Muscular Dystrophy.
    Norcia G; Lucibello S; Coratti G; Onesimo R; Pede E; Ferrantini G; Brogna C; Cicala G; Carnicella S; Forcina N; Fanelli L; Pane M; Mercuri E
    J Neuromuscul Dis; 2021; 8(4):453-456. PubMed ID: 33935100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early developmental milestones in Duchenne muscular dystrophy.
    van Dommelen P; van Dijk O; de Wilde JA; Verkerk PH
    Dev Med Child Neurol; 2020 Oct; 62(10):1198-1204. PubMed ID: 32692451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests.
    Miller NF; Alfano LN; Iammarino MA; Connolly AM; Moore-Clingenpeel M; Powers BR; Tsao CY; Waldrop MA; Flanigan KM; Mendell JR; Lowes LP
    Pediatr Neurol; 2020 Dec; 113():15-20. PubMed ID: 32979653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boys With Duchenne Muscular Dystrophy: 1-Year Locomotor Changes in Relation to a Control Group.
    Martini J; Caromano FA; Carvalho EV; Goya PA; Hayasaka RM; Nakazune S; Fávero FM; Voos MC
    Percept Mot Skills; 2018 Feb; 125(1):40-56. PubMed ID: 29171337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy.
    Kempen JC; Harlaar J; van der Kooi AJ; de Groot IJ; van den Bergen JC; Niks EH; Verschuuren JJ; Brehm MA
    Neuromuscul Disord; 2014 Mar; 24(3):216-21. PubMed ID: 24365209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early neurodevelopmental assessment in Duchenne muscular dystrophy.
    Pane M; Scalise R; Berardinelli A; D'Angelo G; Ricotti V; Alfieri P; Moroni I; Hartley L; Pera MC; Baranello G; Catteruccia M; Casalino T; Romeo DM; Graziano A; Gandioli C; Bianco F; Mazzone ES; Lombardo ME; Scoto M; Sivo S; Palermo C; Gualandi F; Sormani MP; Ferlini A; Bertini E; Muntoni F; Mercuri E
    Neuromuscul Disord; 2013 Jun; 23(6):451-5. PubMed ID: 23535446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor and cognitive delay in Duchenne muscular dystrophy: implication for early diagnosis.
    Mirski KT; Crawford TO
    J Pediatr; 2014 Nov; 165(5):1008-10. PubMed ID: 25149498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network.
    Connolly AM; Florence JM; Cradock MM; Malkus EC; Schierbecker JR; Siener CA; Wulf CO; Anand P; Golumbek PT; Zaidman CM; Philip Miller J; Lowes LP; Alfano LN; Viollet-Callendret L; Flanigan KM; Mendell JR; McDonald CM; Goude E; Johnson L; Nicorici A; Karachunski PI; Day JW; Dalton JC; Farber JM; Buser KK; Darras BT; Kang PB; Riley SO; Shriber E; Parad R; Bushby K; Eagle M;
    Neuromuscul Disord; 2013 Jul; 23(7):529-39. PubMed ID: 23726376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
    Wein N; Alfano L; Flanigan KM
    Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short developmental milestone risk assessment tool to identify Duchenne muscular dystrophy in primary care.
    van Dommelen P; van Dijk O; de Wilde JA; Verkerk PH
    Orphanet J Rare Dis; 2024 May; 19(1):192. PubMed ID: 38730494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DMD and West syndrome.
    Cardas R; Iliescu C; Butoianu N; Seferian A; Gataullina S; Gargaun E; Nectoux J; Bienvenu T; Craiu D; Gidaro T; Servais L
    Neuromuscul Disord; 2017 Oct; 27(10):911-913. PubMed ID: 28802771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler development.
    Connolly AM; Florence JM; Cradock MM; Eagle M; Flanigan KM; McDonald CM; Karachunski PI; Darras BT; Bushby K; Malkus EC; Golumbek PT; Zaidman CM; Miller JP; Mendell JR;
    Pediatr Neurol; 2014 Jun; 50(6):557-63. PubMed ID: 24842254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of motor proficiency and functional ambulation in Duchenne muscular dystrophy with healthy peers.
    Yildiz S; Sahin S; Bulut N; Tunca Yilmaz O; Karaduman AA; Akel BS
    Somatosens Mot Res; 2020 Dec; 37(4):252-256. PubMed ID: 32583706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community.
    Elhawary NA; Jiffri EH; Jambi S; Mufti AH; Dannoun A; Kordi H; Khogeer A; Jiffri OH; Elhawary AN; Tayeb MT
    Hum Genomics; 2018 Apr; 12(1):18. PubMed ID: 29631625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials.
    Alfano LN; Miller NF; Berry KM; Yin H; Rolf KE; Flanigan KM; Mendell JR; Lowes LP
    Neuromuscul Disord; 2017 May; 27(5):452-457. PubMed ID: 28279570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials.
    Gissy JJ; Johnson T; Fox DJ; Kumar A; Ciafaloni E; van Essen AJ; Peay HL; Martin A; Lucas A; Finkel RS;
    Neuromuscul Disord; 2017 Oct; 27(10):905-910. PubMed ID: 28739181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability and pharmacokinetics of eteplirsen in young boys aged 6-48 months with Duchenne muscular dystrophy amenable to exon 51 skipping.
    Mercuri E; Seferian AM; Servais L; Deconinck N; Stevenson H; Ni X; Zhang W; East L; Yonren S; Muntoni F;
    Neuromuscul Disord; 2023 Jun; 33(6):476-483. PubMed ID: 37207382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
    McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Elfring GL; Atkinson L; Reha A; Hirawat S; Miller LL
    Muscle Nerve; 2010 Apr; 41(4):500-10. PubMed ID: 19941337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy.
    Zamani G; Hosseinpour S; Ashrafi MR; Mohammadi M; Badv RS; Tavasoli AR; Akbari MG; Bereshneh AH; Malamiri RA; Heidari M
    BMC Neurol; 2022 May; 22(1):162. PubMed ID: 35501714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal motor function in proximal versus distal DMD pathogenic variants.
    Thangarajh M; Bello L; Gordish-Dressman H;
    Muscle Nerve; 2021 Oct; 64(4):467-473. PubMed ID: 34255858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.